TY  - JOUR
T1  - Review on Diagnosis and Management of Cauda Equina
A1  - Hosam Zakaria Mohamed
A1  - Munira Sajir AL Qahtani
A1  - Abdalmajid Hisham AL Hakeem
A1  - Raghad Mohammed Al Amri
A1  - Muhannad Ibrahim Al kuraydis
A1  - Hussain Ali Bu Shehab
A1  - Faris Mohammad Aljohani
A1  - Omar Mater Alruwaili
A1  - Aqeelah Mansour Alyaqoub
A1  - Duaa Ahmed Ali AL Abbas
A1  - Raghad Shari Wazi Al Shahrani
JF  - International Journal of Pharmaceutical Research and Allied Sciences
JO  - Int J Pharm Res Allied Sci
SN  - 2277-3657
Y1  - 2023
VL  - 12
IS  - 1
DO  - 10.51847/aW8Pkq8KiB
SP  - 95
EP  - 99
N2  - Disorders of the cauda equina are etiologically and physically connected to the neuromuscular system in the spinal cord. A thorough history and neurological examination are necessary for clinical recognition of a cauda equina-affecting condition, and to make a rapid diagnosis, the selection and interpretation of relevant neuroimaging investigations, neurophysiologic testing, and laboratory tests are necessary. The diagnosis and treatment of Cauda Equina Syndrome (CES) are difficult. It could appear at any time or in any environment. It is most common between the ages of 31 and 50. Intervertebral disk herniation was the most frequent cause of conus medullaris and cauda equina lesions, followed by spinal fracture. The Medline, Pubmed, Embase, NCBI, and Cochrane databases were searched for studies of patients with non-alcoholic fatty liver disease. Incidence, etiology, and management options were analyzed. Most academic studies concur that CES is a rare ailment among people who suffer from back pain overall. It is obvious that not all patients with back pain will experience CES, hence not every patient has to be warned. Patients who might eventually develop CES should be "safety-netted" with attentive observation.
UR  - https://ijpras.com/article/review-on-diagnosis-and-management-of-cauda-equina-yufgtrtgw8lgadh
ER  -